{"transactions":[{"id":3584711,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":158952,"kind":"person","name":"MAULDIN JOHN F","position":1,"cik":"0001522480","reported_name":"MAULDIN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-03-21T00:58:19.000Z","date":"2019-03-15","kind":"sale","acquired":false,"shares":50000,"price":1.65,"value":82500.0,"ownership":{"direct":false,"nature":"Retirement Plans"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Warrants held in retirement plans of companies controlled by Mr. Mauldin."}],"balance_after":0,"derivative":{"exercise_price":2.5,"exercise_date":"2018-11-27","expiration_date":"2019-03-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-020692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919119020692/doc4.xml","form_type":"4"}},{"id":3597261,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":158952,"kind":"person","name":"MAULDIN JOHN F","position":1,"cik":"0001522480","reported_name":"MAULDIN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Pruchase Common Stock","published_at":"2019-03-14T00:53:56.000Z","date":"2019-03-11","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will become exercisable in four equal quarterly installments from the date of grant on March 11, 2019 provided that the grantee remains a director on the last day of the applicable calendar quarter."}],"balance_after":65000,"derivative":{"exercise_price":4.28,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-19-019311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919119019311/doc4.xml","form_type":"4"}},{"id":4517220,"issuer":{"id":5577,"kind":"organization","name":"GALECTIN THERAPEUTICS INC"},"owners":[{"id":158952,"kind":"person","name":"MAULDIN JOHN F","position":1,"cik":"0001522480","reported_name":"MAULDIN JOHN F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2016-12-19T21:27:16.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting."}],"balance_after":31250,"derivative":{"exercise_price":0.89,"expiration_date":"2026-12-15","underlying":"Common stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001179022-16-000134","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133416/000117902216000134/edgar.xml","form_type":"4"}}]}